Moreover, CRC cells co-injected with KRAS-Mφ (3/5, 60%) or siMOCK-Mφ (3/5, 60%) were shown to be more likely to develop liver metastasis (Fig. 3b, c). This evidence concerns the gene KRAS and colorectal carcinoma.